– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end

Perforator Yandex introduces Perforator, a tool that can identify and evaluate code inefficiencies across a company’s entire code base. Perforator helps developers identify the most resource-intensive sections of code and provides detailed statistics for subsequent optimization. The solution can help businesses reduce CPU resource usage by 20% annually. By leveraging

Report finds that internet users have passed the 5.5 billion mark, with 136 million new users added in the last 12 months SAN FRANCISCO, Feb. 05, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, and We Are Social, the socially-led creative agency, have released